| FLNA |
FLNA, FLN, FLN1: Filamin-A |
EHD1 |
EHD1, PAST, CDABP0131, PAST1: EH domain-containing protein 1 |
0.36 |
Evidence |
|
| FLNA |
FLNA, FLN, FLN1: Filamin-A |
ACTR3 |
ACTR3, ARP3: Actin-related protein 3 |
0.36 |
Evidence |
|
| MAG |
MAG, GMA: Myelin-associated glycoprotein precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.36 |
Evidence |
|
| MAG |
MAG, GMA: Myelin-associated glycoprotein precursor |
ITGAE |
ITGAE: Integrin alpha-E precursor |
0.36 |
Evidence |
|
| C4BPB |
C4BPB: C4b-binding protein beta chain precursor |
SERPINF1 |
SERPINF1, PEDF: Pigment epithelium-derived factor precursor |
0.36 |
Evidence |
|
| CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.36 |
Evidence |
|
| CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
SLAMF1 |
SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor |
0.36 |
Evidence |
|
| CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
ITGAE |
ITGAE: Integrin alpha-E precursor |
0.36 |
Evidence |
|
| CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
CD82 |
CD82, KAI1, SAR2, ST6, TSPAN27: CD82 antigen |
0.36 |
Evidence |
|
| CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
ADAM17 |
ADAM17, CSVP, TACE: ADAM 17 precursor |
0.36 |
Evidence |
|
| CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
0.36 |
Evidence |
|
| CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
0.36 |
Evidence |
|
| EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
0.36 |
Evidence |
|
| ITIH1 |
ITIH1, IGHEP1: Inter-alpha-trypsin inhibitor heavy chain H1 precursor |
PCOLCE |
PCOLCE, PCPE1: Procollagen C-endopeptidase enhancer 1 precursor |
0.36 |
Evidence |
|
| CD58 |
CD58, LFA3: Lymphocyte function-associated antigen 3 precursor |
SELL |
SELL, LNHR, LYAM1: L-selectin precursor |
0.36 |
Evidence |
|
| CD58 |
CD58, LFA3: Lymphocyte function-associated antigen 3 precursor |
CD47 |
CD47, MER6: Leukocyte surface antigen CD47 precursor |
0.36 |
Evidence |
|
| CD58 |
CD58, LFA3: Lymphocyte function-associated antigen 3 precursor |
ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
0.36 |
Evidence |
|
| CD58 |
CD58, LFA3: Lymphocyte function-associated antigen 3 precursor |
ITGB7 |
ITGB7: Integrin beta-7 precursor |
0.36 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
PRKCQ |
PRKCQ, PRKCT: Protein kinase C theta type |
0.36 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
PRKD2 |
PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 |
0.36 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
RASA3 |
RASA3: Ras GTPase-activating protein 3 |
0.36 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
STK4 |
STK4, MST1: Serine/threonine-protein kinase 4 |
0.36 |
Evidence |
|
| GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
GRM1 |
GRM1, GPRC1A, MGLUR1: Metabotropic glutamate receptor 1 precursor |
0.36 |
Evidence |
|
| XRCC1 |
XRCC1: DNA-repair protein XRCC1 |
CSPG6 |
SMC3, BAM, BMH, CSPG6, SMC3L1: Structural maintenance of chromosomes protein 3 |
0.36 |
Evidence |
|
| XRCC1 |
XRCC1: DNA-repair protein XRCC1 |
SMC1L1 |
SMC1A, DXS423E, KIAA0178, SB1.8, SMC1, SMC1L1: Structural maintenance of chromos |
0.36 |
Evidence |
|